WallStreetZenWallStreetZen

NASDAQ: EPIX
Essa Pharma Inc Stock Forecast, Predictions & Price Target

Analyst price target for EPIX

Based on 2 analysts offering 12 month price targets for Essa Pharma Inc.
Min Forecast
$17.00+198.25%
Avg Forecast
$17.00+198.25%
Max Forecast
$17.00+198.25%

Should I buy or sell EPIX stock?

Based on 2 analysts offering ratings for Essa Pharma Inc.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their EPIX stock forecasts and price targets.

EPIX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-16
lockedlocked$00.00+00.00%2023-12-13

1 of 1

Forecast return on equity

Is EPIX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.39%

Forecast return on assets

Is EPIX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

EPIX revenue forecast

What is EPIX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$22.3M
Avg 2 year Forecast
$174.4M
Avg 3 year Forecast
$144.1M

EPIX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
EPIX$5.70$17.00+198.25%Buy
CDXS$3.61$9.00+149.31%Strong Buy
QSI$1.80$4.00+122.22%Buy
IPSC$3.01$14.67+387.28%Strong Buy
CDXC$3.30$6.00+81.82%Strong Buy

Essa Pharma Stock Forecast FAQ

Is Essa Pharma Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: EPIX) stock is to Buy EPIX stock.

Out of 2 analysts, 0 (0%) are recommending EPIX as a Strong Buy, 2 (100%) are recommending EPIX as a Buy, 0 (0%) are recommending EPIX as a Hold, 0 (0%) are recommending EPIX as a Sell, and 0 (0%) are recommending EPIX as a Strong Sell.

If you're new to stock investing, here's how to buy Essa Pharma stock.

What is EPIX's revenue growth forecast for 2026-2028?

(NASDAQ: EPIX) Essa Pharma's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.19%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.95%.

Essa Pharma's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast EPIX's revenue for 2026 to be $987,963,810, with the lowest EPIX revenue forecast at $987,963,810, and the highest EPIX revenue forecast at $987,963,810. On average, 1 Wall Street analysts forecast EPIX's revenue for 2027 to be $7,736,462,000, with the lowest EPIX revenue forecast at $7,736,462,000, and the highest EPIX revenue forecast at $7,736,462,000.

In 2028, EPIX is forecast to generate $6,391,065,572 in revenue, with the lowest revenue forecast at $1,297,617,487 and the highest revenue forecast at $15,077,206,121.

What is EPIX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: EPIX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is EPIX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year EPIX price target, the average EPIX price target is $17.00, with the highest EPIX stock price forecast at $17.00 and the lowest EPIX stock price forecast at $17.00.

On average, Wall Street analysts predict that Essa Pharma's share price could reach $17.00 by May 16, 2025. The average Essa Pharma stock price prediction forecasts a potential upside of 198.25% from the current EPIX share price of $5.70.

What is EPIX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: EPIX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.